Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Lung cancer screening - risk stratification : Who should undergo screening?].

Der Radiologe - 1 Sept 2016

Beer L, Prosch H

Abstract excerpt

Lung cancer is one of the leading causes of deaths in Europa and the USA. In approximately 75 % of lung cancer patients, bronchogenic carcinoma is detected at an advanced tumor stage; therefore, therapeutic options which aim at curing the disease in these patients are limited and treatment is mostly palliative. A relatively good prognosis is reserved for the minority of patients where the tumor is detected at an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Europe
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Internationality

Share to Overweight

Share to Patient Selection

Share to Survival Rate

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 27495786
DOI: 10.1007/s00117-016-0152-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Lung cancer screening - risk stratification : Who should undergo screening?].PMID 27495786Read ↗

[The Cutting-edge of Medicine; Clinico-pathogenetic background and approach for early detection of lung cancer].Semantic proximity Read ↗

[Lung cancer: progress in diagnosis and treatments. Topics: II. Diagnosis and examination; 3. Pathological diagnosis, molecular testing and biomarkers].Semantic proximity Read ↗

Lung cancer: current therapies and new targeted treatments.Semantic proximity Read ↗

[Lung cancer].Semantic proximity Read ↗

[Basic principles for the prevention, diagnosis and therapy of lung cancer].Semantic proximity Read ↗

Lung cancer epidemiology and genetics.Semantic proximity Read ↗

SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection.Semantic proximity Read ↗

Risk factors for lung cancer worldwide.Semantic proximity Read ↗

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors.Semantic proximity Read ↗

A database for lung cancer prediction models - a Danish cohort study of nearly 40,000 patientsSemantic proximity Read ↗

Survival of Lung Cancer Patients Considering Criteria for Lung Cancer Screening: Analysis of the Korean Lung Cancer Registry, 2014-2016Semantic proximity Read ↗

Current challenges in lung cancer early detection biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.